calcium dobesilate has been researched along with omega-n-methylarginine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jongh, RT; de Vries, G; Kamper, AM; Lampe, D; Nanayakkara, PW; Schalkwijk, CG; Scheffer, PG; Schram, MT; Serné, EH; Stam, F; Stehouwer, CD; Tushuizen, ME; van Dijk, RA | 1 |
1 trial(s) available for calcium dobesilate and omega-n-methylarginine
| Article | Year |
|---|---|
The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers: a placebo-controlled randomised clinical trial.
Topics: Adolescent; Adult; Alanine Transaminase; Biomarkers; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Dobesilate; Capillaries; Diastole; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Follow-Up Studies; Forearm; Heart Rate; Hemostatics; Humans; Ketocholesterols; Lipoproteins, LDL; Male; Microcirculation; Middle Aged; Nitric Oxide Donors; Nitroprusside; Obesity; omega-N-Methylarginine; Oxidation-Reduction; Patient Compliance; Reference Values; Regional Blood Flow; Smoking; Systole; Treatment Outcome; Vasodilation; Vasodilator Agents | 2003 |